“It's that invisible illness”: Patient and clinician perspectives on outcomes in pulmonary arterial hypertension treatment is a research paper published in Pulmonary Circulation (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: K23HL163402
National Heart, Lung, and Blood Institute
Grant: L30HL154185
NHLBI NIH HHS
Grant: K23 HL143181
National Heart, Lung, and Blood Institute
Grant: R01‐134905
NHLBI NIH HHS
Grant: K24 HL103844
National Heart, Lung, and Blood Institute
Grant: K24‐HL103844
National Heart, Lung, and Blood Institute
Grant: R01‐159997
National Institutes of Health
Grant: 5K23HL163402-03
Developing and Evaluating Quality-Weighted Hospital-Free Days as a Novel, Patient-Centered Outcome for Trials of Patients with Acute Respiratory Failure
National Institutes of Health
Grant: 5R01HL134905-02
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
National Institutes of Health
Grant: 5K24HL103844-03
Aromatase Inhibitors in Pulmonary Vascular Complications of Liver Disease
National Institutes of Health
Grant: 5R01HL159997-05
Physical Activity in Pulmonary Arterial Hypertension (ACTiPH)
National Institutes of Health
Grant: 5K23HL143181-04
Identifying palliative care needs among hospitalized patients with chronic obstructive pulmonary disease
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords